Remission of lupus nephritis: the trajectory of histological response in successfully treated patients

被引:14
作者
Malvar, Ana [1 ]
Alberton, Valeria [1 ]
Lococo, Bruno [1 ]
Lourenco, Maria [1 ]
Martinez, Joaquin [1 ]
Burna, Lucrecia [1 ]
Besso, Celeste [1 ]
Navarro, Jordi [1 ]
Nagaraja, Haikady N. [2 ]
Khatiwada, Aastha [3 ]
Wolf, Bethany [4 ]
Rovin, Brad [5 ]
机构
[1] Hosp Fernandez, Nephrol Unit, Buenos Aires, Argentina
[2] Ohio State Univ, Coll Publ Hlth, Div Biostat, Columbus, OH USA
[3] Natl Jewish Hlth, Dept Biostat & Bioinformat, Denver, CO USA
[4] Med Univ South Carolina, Dept Publ Hlth Sci, Charleston, SC USA
[5] Ohio State Univ, Wexner Med Ctr, Internal Med Nephrol, Columbus, OH 43210 USA
关键词
lupus nephritis; inflammation; autoimmune diseases; CLASSIFICATION; INCIDENT;
D O I
10.1136/lupus-2023-000932
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
ObjectiveThis study investigated changes in kidney histology over time in patients with lupus nephritis (LN) undergoing immunosuppressive treatment.MethodsPatients with proliferative +/- membranous LN were studied. After a diagnostic kidney biopsy (Bx1), patients had protocol biopsy 2 (Bx2) at 9 (6-15) months and protocol biopsy 3 (Bx3) at 42 (28-67) months. Kidney histological activity and chronicity indices (AI, CI) were measured.ResultsAI declined in a biphasic fashion, falling rapidly between Bx1 and Bx2 and then more slowly between Bx2 and Bx3. Patients were divided into those who achieved histological remission, defined as an AI=0 at Bx3 (group 1), and those with persistent histological activity (AI >0) at Bx3 (group 2). The early decline in AI was 1.6 times greater (95% CI 1.30, 1.91) in group 1 than group 2 (p=0.01). Between Bx2 and Bx3, the AI decline was 2.19-fold greater (95% CI 2.09, 2.29) in group 1 versus group 2 (p=7.34x10(-5)). Individual histological components of the AI resolved at different rates. Inflammatory lesions like glomerular crescents, karyorrhexis and necrosis mostly resolved by Bx2, whereas endocapillary hypercellularity, subendothelial hyaline deposits and interstitial inflammation resolved slowly, accounting for residual histological activity at biopsy 3 in group 2. In contrast, CI increased rapidly, by 0.15 units/month between Bx1 and Bx2, then plateaued. There were no differences in the rate of accumulation of chronic damage between group 1 and group 2. The increase in CI was significantly related to the severity of glomerular crescents (p=0.044), subendothelial hyaline deposits (p=0.002) and interstitial inflammation (p=0.015) at Bx1.ConclusionsLN histological activity takes months to years to resolve, providing a rationale for the need of long-term, well-tolerated maintenance immunosuppression. Despite responding, LN kidneys accrue chronic damage early during treatment. This finding provides an explanation for the association of chronic progressive kidney disease with recurrent episodes of LN.
引用
收藏
页数:10
相关论文
共 18 条
[1]   Lupus nephritis [J].
Anders, Hans-Joachim ;
Saxena, Ramesh ;
Zhao, Ming-hui ;
Parodis, Ioannis ;
Salmon, Jane E. ;
Mohan, Chandra .
NATURE REVIEWS DISEASE PRIMERS, 2020, 6 (01)
[2]   Revision of the International Society of Nephrology/Renal Pathology Society classification for lupus nephritis: clarification of definitions, and modified National Institutes of Health activity and chronicity indices [J].
Bajema, Ingeborg M. ;
Wilhelmus, Suzanne ;
Alpers, Charles E. ;
Bruijn, Jan A. ;
Colvin, Robert B. ;
Cook, H. Terence ;
D'Agati, Vivette D. ;
Ferrario, Franco ;
Haas, Mark ;
Jennette, J. Charles ;
Joh, Kensuke ;
Nast, Cynthia C. ;
Noel, Laure-Helene ;
Rijnink, Emilie C. ;
Roberts, Ian S. D. ;
Seshan, Surya V. ;
Sethi, Sanjeev ;
Fogo, Agnes B. .
KIDNEY INTERNATIONAL, 2018, 93 (04) :789-796
[3]   A prospective observational cohort study highlights kidney biopsy findings of lupus nephritis patients in remission who flare following withdrawal of maintenance therapy [J].
De Rosa, Marcelo ;
Azzato, Francisco ;
Toblli, Jorge E. ;
De Rosa, Graciela ;
Fuentes, Federico ;
Nagaraja, Haikady N. ;
Nash, Ryan ;
Rovin, Brad H. .
KIDNEY INTERNATIONAL, 2018, 94 (04) :788-794
[4]  
DIAMOND JR, 1990, AM J PATHOL, V137, P1323
[5]   Worse long-term renal outcome of lupus nephritis patients of African descent living in Europe [J].
Enfrein, Antoine ;
Pirson, Valerie ;
Le Guern, Veronique ;
Karras, Adexandre ;
Tamirou, Farah ;
Costedoat-Chalumeau, Nathalie ;
Houssiau, Frederic .
RMD OPEN, 2022, 8 (02)
[6]   2019 Update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritis [J].
Fanouriakis, Antonis ;
Kostopoulou, Myrto ;
Cheema, Kim ;
Anders, Hans-Joachim ;
Aringer, Martin ;
Bajema, Ingeborg ;
Boletis, John ;
Frangou, Eleni ;
Houssiau, Frederic A. ;
Hollis, Jane ;
Karras, Adexandre ;
Marchiori, Francesca ;
Marks, Stephen D. ;
Moroni, Gabriella ;
Mosca, Marta ;
Parodis, Ioannis ;
Praga, Manuel ;
Schneider, Matthias ;
Smolen, Josef S. ;
Tesar, Vladimir ;
Trachana, Maria ;
van Vollenhoven, Ronald F. ;
Voskuyl, Alexandre E. ;
Teng, Y. K. Onno ;
van Leew, Bernadette ;
Bertsias, George ;
Jayne, David ;
Boumpas, Dimitrios T. .
ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 (06) :713-723
[7]   Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis [J].
Furie, Richard ;
Rovin, Brad H. ;
Houssiau, Frederic ;
Malvar, Ana ;
Teng, Y. K. Onno ;
Contreras, Gabriel ;
Amoura, Zahir ;
Yu, Xueqing ;
Mok, Chi-Chiu ;
Santiago, Mittermayer B. ;
Saxena, Amit ;
Green, Yulia ;
Ji, Beulah ;
Kleoudis, Christi ;
Burriss, Susan W. ;
Barnett, Carly ;
Roth, David A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (12) :1117-1128
[8]  
Kopp JB, 1996, LAB INVEST, V74, P991
[9]   Kidney biopsy-based management of maintenance immunosuppression is safe and may ameliorate flare rate in lupus nephritis [J].
Malvar, Ana ;
Alberton, Valeria ;
Lococo, Bruno ;
Ferrari, Matias ;
Delgado, Pamela ;
Nagaraja, Haikady N. ;
Rovin, Brad H. .
KIDNEY INTERNATIONAL, 2020, 97 (01) :156-162
[10]   Histologic versus clinical remission in proliferative lupus nephritis [J].
Malvar, Ana ;
Pirruccio, Paola ;
Alberton, Valeria ;
Lococo, Bruno ;
Recalde, Cecilia ;
Fazini, Bernanda ;
Nagaraja, Haikady ;
Indrakanti, Divya ;
Rovin, Brad H. .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32 (08) :1338-1344